Bandingkan Harga & Kinerja Cashlez Worldwide Indonesia Tbk. (CASH) vs UBC Medical Indonesia Tbk. (LABS)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Cashlez Worldwide Indonesia Tbk. dan UBC Medical Indonesia Tbk.: Cashlez Worldwide Indonesia Tbk. diperdagangkan di Rp200 (kapitalisasi pasar 289,12 M, volume 24 jam 1,42 jt), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp148 (kapitalisasi pasar 576,7 M, volume 24 jam 3,14 jt). Perbedaan utamanya: UBC Medical Indonesia Tbk. lebih besar dari sisi kapitalisasi pasar, dan UBC Medical Indonesia Tbk. lebih aktif diperdagangkan (3,14 jt vs 1,42 jt). Mana yang lebih baik tergantung tujuan investasimu.
| CASH | LABS | |
|---|---|---|
Kapitalisasi Pasar | 289,12 M | 576,7 M |
Volume | 1,42 jt | 3,14 jt |
Lot | 14,18 rb | 31,39 rb |
Perputaran | 285,22 jt | 472,14 jt |
Harga Rata-rata | 201,13 | 150,43 |
Nilai Transaksi | 285,22 jt | 472,14 jt |
Harga Ekuilibrium Indikatif | — | 147 |
Volume Ekuilibrium Indikatif | — | 311 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Cashlez Worldwide Indonesia Tbk.
PT Cashlez Worldwide Indonesia Tbk (the Company) was established based on Notarial DeedNo. 1 dated January 12, 2015 of public notary Novita Puspitarini, S.H. The Company started its commercial operations in 2016.
Selengkapnya di halaman CASH →Tentang UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →
